Health
Hims & Hers Launches Multi-Cancer Early Detection Testing, Connecting Customers to Cutting-Edge Proactive Care
SAN FRANCISCO, February 04, 2026--Today, Hims & Hers Health, Inc. (NYSE: HIMS), the leading digital health and wellness platform, launched access to the Hims & Hers Multi-Cancer Test by Galleri®, a simple cancer screening blood test that can detect a signal for 50+ types of cancer even before symptoms appear1. This multi-cancer early detection (MCED) test combines Hims & Hers’ scale with GRAIL’s innovative cancer screening technology to dramatically increase access to proactive care.
About this update from Hims & Hers Health, Inc.
[{"type":"image","alt":"The company will offer access to Galleri®, an innovative blood test from GRAIL, Inc. that screens for more than 50 types of cancer.","displaySize":"","headline":null,"caption":"The company will offer access to Galleri®, an innovative blood test from GRAIL, Inc. that screens for more than 50 types of cancer.","credit":null,"className":"","disableSlideshowImg":false,"size":{"original":{"width":480,"height":252,"url":"https://media.zenfs.com/en/business-wire.com/822e2d38fe91a92ab838b5539d995b0b"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/0XwNnNzOVMOZkcy6ReDjow--/YXBwaWQ9aGlnaGxhbmRlcjt3PTk2MDtoPTUwNDtjZj13ZWJw/https://media.zenfs.com/en/business-wire.com/822e2d38fe91a92ab838b5539d995b0b","width":480,"height":252}},"lazy":false},{"type":"image","alt":"","displaySize":"","headline":null,"caption":"","credit":null,"className":"","disableSlideshowImg":false,"size":{"original":{"width":2562,"height":408,"url":"https://media.zenfs.com/en/business-wire.com/f938f0ce1baa4113be2bc8e5b41c85a7"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/wwVHYdq2Q.Ob29aI5vElgg--/YXBwaWQ9aGlnaGxhbmRlcjt3PTk2MDtoPTE1MztjZj13ZWJw/https://media.zenfs.com/en/business-wire.com/f938f0ce1baa4113be2bc8e5b41c85a7","width":960,"height":153},"lightbox":{"url":"https://s.yimg.com/ny/api/res/1.2/F51ExLB7U75DaHXcvFoZCQ--/YXBwaWQ9aGlnaGxhbmRlcjt3PTI0MDA7aD0zODI7Y2Y9d2VicA--/https://media.zenfs.com/en/business-wire.com/f938f0ce1baa4113be2bc8e5b41c85a7","width":1200,"height":191}}},{"type":"text","content":"The company will offer access to Galleri®, an innovative blood test from GRAIL, Inc. that screens for more than 50 types of cancer","length":130,"tagName":"p","attribs":{}},{"type":"text","content":"SAN FRANCISCO, February 04, 2026--(BUSINESS WIRE)--Today, Hims & Hers Health, Inc. (NYSE: HIMS), the leading digital health and wellness platform, launched access to the Hims & Hers Multi-Cancer Test by Galleri®, a simple cancer screening blood test that can detect a signal for 50+ types of cancer even before symptoms appear1. This multi-cancer early detection (MCED) test combines Hims & Hers’ scale with GRAIL’s innovative cancer screening technology to dramatically increase access to proactive care.","length":517,"tagName":"p"},{"type":"text","content":"More than one in three people will develop cancer in their lifetime2, but many cancers can go ...